全文获取类型
收费全文 | 1739篇 |
免费 | 112篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 45篇 |
妇产科学 | 20篇 |
基础医学 | 169篇 |
口腔科学 | 116篇 |
临床医学 | 95篇 |
内科学 | 453篇 |
皮肤病学 | 21篇 |
神经病学 | 99篇 |
特种医学 | 113篇 |
外科学 | 300篇 |
综合类 | 6篇 |
一般理论 | 1篇 |
预防医学 | 61篇 |
眼科学 | 87篇 |
药学 | 73篇 |
肿瘤学 | 186篇 |
出版年
2023年 | 15篇 |
2022年 | 9篇 |
2021年 | 45篇 |
2020年 | 32篇 |
2019年 | 48篇 |
2018年 | 71篇 |
2017年 | 40篇 |
2016年 | 42篇 |
2015年 | 58篇 |
2014年 | 81篇 |
2013年 | 68篇 |
2012年 | 118篇 |
2011年 | 115篇 |
2010年 | 65篇 |
2009年 | 80篇 |
2008年 | 105篇 |
2007年 | 106篇 |
2006年 | 104篇 |
2005年 | 102篇 |
2004年 | 107篇 |
2003年 | 103篇 |
2002年 | 103篇 |
2001年 | 15篇 |
2000年 | 10篇 |
1999年 | 19篇 |
1998年 | 15篇 |
1997年 | 16篇 |
1996年 | 15篇 |
1995年 | 16篇 |
1994年 | 19篇 |
1993年 | 7篇 |
1992年 | 7篇 |
1991年 | 7篇 |
1990年 | 7篇 |
1989年 | 8篇 |
1988年 | 4篇 |
1986年 | 5篇 |
1984年 | 10篇 |
1983年 | 11篇 |
1982年 | 7篇 |
1981年 | 3篇 |
1980年 | 2篇 |
1979年 | 4篇 |
1978年 | 2篇 |
1977年 | 5篇 |
1976年 | 3篇 |
1965年 | 2篇 |
1961年 | 2篇 |
1908年 | 2篇 |
1907年 | 2篇 |
排序方式: 共有1861条查询结果,搜索用时 15 毫秒
1.
Cristina Masini Maria Giuseppa Vitale Marco Maruzzo Giuseppe Procopio Ugo de Giorgi Sebastiano Buti Sabrina Rossetti Roberto Iacovelli Francesco Atzori Laura Cosmai Francesca Vignani Giuseppe Prati Sarah Scagliarini Annalisa Guida Annalisa Berselli Carmine Pinto 《Clinical genitourinary cancer》2019,17(1):e150-e155
Background
Pazopanib has been approved for first-line treatment of patients with metastatic renal-cell carcinoma on the basis of clinical trials that enrolled only patients with adequate renal function. Few data are available on the safety and efficacy of pazopanib in patients with renal insufficiency. This study investigated the effect of kidney function on treatment outcomes in such patients.Patients and Methods
We retrospectively analyzed data of metastatic renal-cell carcinoma patients treated with pazopanib from January 2010 to June 2016 with respect to renal function. Patients with Modification of Diet in Renal Disease ≤ 60 mL/min/1.73 m2 (group A) were compared to patients with Modification of Diet in Renal Disease > 60 mL/min/1.73 m2 (group B) in terms of progression-free survival, toxicities, response rates, and overall survival.Results
A total of 229 patients were included: 128 in group A and 101 in group B. Median progression-free survival was 14 months (95% confidence interval [CI], 9.4-18.5) and 17 months (95% CI, 11.4-22.8), and overall survival was 30.5 months (95% CI, 8-53) and 41.4 months (95% CI, 21-62) for group A and group B, respectively, with no significant difference (P = .6). No significant difference between the 2 groups was reported in the incidence of adverse events. Dose reductions were more frequent in group A patients (66% vs. 36%; P = .04).Conclusion
Although the dose of pazopanib was reduced more frequently in patients with renal impairment, kidney function at therapy initiation does not adversely affect the safety and efficacy of pazopanib. 相似文献2.
Sumanta K. Pal MD Dean Bajorin MD Nazli Dizman MD Jean Hoffman-Censits MD David I. Quinn MD Daniel P. Petrylak MD Matthew D. Galsky MD Ulka Vaishampayan MD Ugo De Giorgi MD Sumati Gupta MD Howard A. Burris MD Harris S. Soifer PhD Gary Li PhD Hao Wang PhD Carl L. Dambkowski MD Susan Moran MD Siamak Daneshmand MD Jonathan E. Rosenberg MD 《Cancer》2020,126(11):2597-2606
3.
4.
5.
6.
Ugo Giordano Claudia Della Corte Giulia Cafiero Daniela Liccardo Attilio Turchetta Kazem Mohammad Hoshemand Danilo Fintini Giorgio Bedogni Maria Chiara Matteucci Valerio Nobili 《European journal of pediatrics》2014,173(11):1511-1518
The aim of this study was to analyse the relationship between insulin–glucose metabolism, nocturnal blood pressure dipping and nonalcoholic fatty liver disease (NAFLD) in obese adolescents without diabetes. One hundred one consecutive children, with biopsy-proven NAFLD, were included in this study. Blood samples were drawn for the analyses of liver function tests, insulin–glucose metabolism and lipid profile appraisal. An ambulatory blood pressure measurement (ABPM) was performed. Seventy-six children (75.3 %) were systolic nondippers, and 23 of them were diastolic nondippers (30.3 %). No differences were found in the anthropometric parameters between the two groups. When compared to the systolic dippers, the systolic nondippers had higher medians of mean nocturnal blood pressure, glucose at 0, 60 and 120 min in the oral glucose tolerance test (OGTT), OGTT insulin at all time points and insulin-resistance values. No correlation of histopathological features with dipping/nondipping statuses was found. Conclusions: We found an association between a nocturnal blood pressure fall and measures of insulin levels, independent of obesity, or daytime blood pressure levels, among the obese patients with NAFLD. Although no association between nondipping profiles and NAFLD was observed in our study, further studies with a longer term follow-up are needed, to better elucidate the complex link between these particular entities. 相似文献
7.
8.
Giovanni Guzzo Ugo Pace Valentina Lo Cascio Giuseppe Craparo Adriano Schimmenti 《Child indicators research》2014,7(1):141-153
The purpose of this study was to examine the relationship between bullying victimization, post-traumatic stress symptoms, and alexithymia. Self-report measures concerning bullying victimization, alexithymia, and post-traumatic stress symptoms were administered to 488 adolescents (52 % boys, 48 % girls) ages 16 to 17 attending high schools. Results show that the experience of being bullied is associated with post-traumatic stress symptoms. Moreover, alexithymia mediated the impact of bullying victimization on post-traumatic stress symptoms. Findings thus show that difficulties identifying and describing feelings combined with an externally oriented thinking, the core symptoms of alexithymia, can play a crucial role in linking bullying victimization with the onset of post-traumatic stress disorder among adolescents. 相似文献
9.
Barone A Crespi R Aldini NN Fini M Giardino R Covani U 《The International journal of oral & maxillofacial implants》2005,20(4):519-525
PURPOSE: Implant placement in the posterior maxilla may often be contraindicated because of insufficient bone volume and the presence of the maxillary sinus. In these situations, sinus floor lifting and grafting frequently have been proposed as the best treatment. The aim of this study was to compare histologically the use of 100% autogenous bone versus a combination of autogenous bone and corticocancellous pig bone for maxillary sinus augmentation. MATERIALS AND METHODS: Eighteen patients requiring bilateral maxillary sinus augmentation were selected for this study. Bone for grafting was harvested from the iliac crest. Each patient received 100% autogenous bone in 1 randomly selected sinus (control side) and a 1:1 mixture of autogenous bone and corticocancellous pig bone particles in the contralateral sinus (test side). Five months after the augmentation procedure, bone biopsy specimens were taken at the time of implant placement. RESULTS: No complications were observed during the surgical procedures; all patients healed uneventfully. No signs or symptoms of maxillary sinus disease were observed during the 5 months after surgery. No significant differences in bone percentages were observed in the bone biopsies from test and control sides. DISCUSSION AND CONCLUSION: It could be concluded from this study that corticocancellous pig bone particles can be successfully used in a 1:1 mixture with autogenous bone from the iliac crest for maxillary sinus augmentation in cases of severely atrophic maxilla. 相似文献
10.
Fabrizio Di Francesco Gennaro De Marco Ugo Antonello Gironi Carnevale Michele Lanza Alessandro Lanza 《Journal of prosthodontic research》2019,63(1):15-24